A 30-year-old woman, gravida 1 para 1, was referred to this hospital with torrential vaginal bleeding for two hours. She had delivered a child by cesarean section 31 days prior. Because her temperature reached 38.5°C, intrauterine infection was suspected. After cesarean section and antibiotic treatment, her temperature returned to normal and then she was discharged from hospital.
Background: This research included 108 patients who had the diognosis the colorectal cancer and liver metastases I,II & III lesion stages (by Gennari) and 18 patients with the diagnosis the hepatocellular cancer. Methods: RFA (a radiofrequency ablation) with the use of the ELEKTROTOM HiTT 106 system by Berhtold firm, Germany, Cool-tip , Covidien, which has an operating frequency 375 kilohertz and a power 0-60 Watt. MWA (a microwave ablation) with the use of the device Ave Cure MWG 881 (Med Waves), which has a power of exposure 32 wattAE of 2 watt, output frequency microwave :902-928 Megahertz and a set of various catheters (antennas) ,which have a thickness from 12 to 16 Gedg and the length of a core from 2,0 to 4,0. Results: RFA:the lethal outcome was in 2 observations. The overall survival of patients was: one-year-73,5%, twoyear-53,3%, three-year-32,1%. MWA:the overall survival of patients was:one-year-78,5%, two-year-old-63,3% & three-year-58,3%. Conclusion: The application of MWA method is less traumatic if we compare it with RFA one. It allows us to expand the indications in groups of patients with primary and secondary cancer of a liver. Percutaneous microwave ablation (MWA) reduces any risk of complications at somatic burdened patients, due to minimally invasive and the result of it is much higher survival.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.